ANNE MCGUINNESS: Open Payments
NPI 1043932510 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,839 in 147 payments from 21 companies in 2025. Trend: 2023 $31 · 2024 $540 · 2025 $2,839
Food & beverage: $2,839
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $661 |
| Phathom Pharmaceuticals, Inc. | 12 | $289 |
| Janssen Biotech, Inc. | 19 | $260 |
| QOL Medical, LLC | 8 | $248 |
| Ardelyx, Inc. | 11 | $192 |
| Lilly USA, LLC | 12 | $147 |
| Regeneron Healthcare Solutions, Inc. | 7 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $136 |
| Intercept Pharmaceuticals, Inc. | 5 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
Products named: VOQUEZNA, RINVOQ, TREMFYA, Sucraid, DUPIXENT, IBSRELA, OMVOH, XIFAXAN.
Industry payments across SC — which companies pay providers there.
